Danaher Target of Unusually Large Options Trading (NYSE:DHR)

Danaher Corporation (NYSE:DHR) saw some unusual options trading on Thursday. Investors acquired 24,187 put options on the company. This represents an increase of approximately 308% compared to the typical daily volume of 5,928 put options.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the stock. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $26,000. Hilton Head Capital Partners LLC acquired a new stake in Danaher in the 4th quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares during the period. JPL Wealth Management LLC acquired a new position in Danaher during the 3rd quarter worth about $25,000. Finally, Main Street Group LTD acquired a new position in Danaher in the 1st quarter valued at about $25,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Guggenheim lowered their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday. Finally, Wolfe Research lowered Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Stock Down 0.3%

DHR stock opened at $191.87 on Friday. Danaher has a one year low of $160.93 and a one year high of $242.80. The firm has a market cap of $134.88 billion, a PE ratio of 34.08, a PEG ratio of 2.40 and a beta of 0.79. The firm’s 50 day moving average price is $185.64 and its 200-day moving average price is $197.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.65.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 21st. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business posted $0.77 earnings per share. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, equities research analysts anticipate that Danaher will post 8.53 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Danaher News Summary

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: J.P. Morgan reiterated a Buy rating on Danaher, which may help support investor confidence after the post-earnings pullback. J.P. Morgan Keeps Their Buy Rating on Danaher (DHR)
• Positive Sentiment: Several articles argue Danaher’s recent slump looks like an overreaction and could be a buying opportunity, suggesting the stock may recover if investors refocus on its long-term fundamentals. Here’s Why the Slump in Danaher Stock This Week Looks Like a Buying Opportunity
• Positive Sentiment: Danaher’s quarterly results beat estimates, with EPS of $1.94 versus $1.85 expected and revenue of $6.27 billion above forecasts, which supports the case that core business performance remains solid. The ‘Standout Performance’ That Could Save Thermo Fisher, Danaher And Others
• Neutral Sentiment: Billionaire investor Dan Loeb reduced his Danaher stake in Q1 2026, adding to sentiment pressure around life sciences tools stocks, though it does not change Danaher’s operating results. Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets
• Neutral Sentiment: Danaher saw unusually heavy put option activity, signaling traders are hedging against more downside in the near term. Don’t Quit on Danaher Stock After Horrific Earnings Reaction

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.